Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women

Journal of Sexual Medicine

Volumn 5, Issue 1, 2008, Pages 132-138

  Çayan, Filiz ^a   Dilek, Umut ^a   Pata, Özlem ^a   Dilek, Saffet ^a  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Hormone therapy; Postmenopausal women; Sexual function

Indexed keywords

DROSPIRENONE; ESTRADIOL; TIBOLONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONAL THERAPY; HUMAN; LUBRICATION; MAJOR CLINICAL STUDY; ORGASM; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SEXUAL AROUSAL; SEXUAL SATISFACTION; TREATMENT DURATION; UTERUS BLEEDING;

EID: 37549024546     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00635.x     Document Type: Article

References (30)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999; 281: 537-44.
2. Çayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E. The prevalence of female sexual dysfunction and potential risk factors that may impaire sexual function in Turkish women. Urol Int 2004; 72: 52-7.
3. Ponholzer A, Roehlich M, Racz U, Temml C, Madersbacher S. Female sexual dysfunction in a healthy Austrian cohort: Prevalence and risk factors. Eur Urol 2005; 47: 366-75.
4. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, Wang T. Sexual problems among women and men aged 40-80y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviours. Int J Impot Res 2005; 17: 39-57.
5. Doruk E, Akbay E, Çayan S, Akbay E, Bozlu M, Acar D. Effect of diabetes mellitus on female sexual function and risk factors. Arch Androl 2005; 51: 1-6.
6. Salonia A, Zanni G, Nappi RE, Briganti A, Deho F, Fabbri F, Colombo R, Guazzoni G, Di Girolamo V, Rigatti P, Montorsi F. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study. Eur Urol 2004; 45: 642-8.
7. Roose SP, Glassman AH, Seidman SN. Relationship between depression and other medical illnesses. JAMA 2001; 286: 1687-90.
8. Çayan S, Bozlu M, Canpolat B, Akbay E. The assessment of sexual functions in women with male partners complaining of erectile dysfunction: Does treatment of male sexual dysfunction improve female partner's sexual functions. J Sex Marital Ther 2005; 30: 333-41.
9. Barber MD, Visco AG, Wyman JF, Fantl JA, Bump RC. Continence program for women research group: Sexual function in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol 2002; 99: 281-9.
10. Eyada M, Atwa M. Sexual function in female patients with unstable angina or non-ST-elevation myocardial infarction. J Sex Med 2007; 4: 1373-80.
11. Schwenkhagen A. Hormonal changes in menopause and implications on sexual health. J Sex Med 2007; 3: 220-6.
12. Davis SR, Guay AT, Shifren JL, Mazer NA. Endocrine aspects of female sexual dysfunction. J Sex Med 2004; 1: 82-6.
13. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: A survey of Western European women. J Sex Med 2006; 3: 212-22.
14. Wylie K, Daines B, Jannini EA, Hallam Jones R, Boul L, Wilson L, Athanasiadis L, Brewster M, Kristensen E. Loss of sexual desire in the postmenopausal woman. J Sex Med 2007; 4: 395-405.
15. Goldstein I. Current management strategies of the postmenopausal patient with sexual health problems. J Sex Med 2007; 3: 235-53.
16. Gonzalez M, Viafara G, Caba F, Molina E. Sexual function, menopause and hormone replacement therapy (HRT). Maturitas 2004; 48: 411-20.
17. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: A literature review. Menopause 2004; 11: 120-30.
18. Modelska K. Female sexual dysfunction in postmenopausal women: Systematic review of placebo-controlled trials. Am J Obstet Gynecol 2003; 188: 286-93.
19. Laan E, van Lunsen RH, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001; 4: 28-41.
20. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R. The female sexual function index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191-208.
21. Dennerstein L, Dudley E, Hopper J. Sexuality, hormones and the menopausal transition. Maturitas 1997; 26: 83-93.
22. Borissova AM, Kovatcheva R, Shinkov A, Vukov M. A study of psychological status and sexuality in middle-aged Bulgarian women: Significance of the hormone replacement therapy. Maturitas 2001; 39: 177-83.
23. Avis NC, Stellato R, Crawford S, Johannes C. Is there an association between menopause status and sexual functioning. Menopause 2000; 7: 297-309.
24. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991; 72: 336-43.
25. Kingsberg S. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women. J Sex Med 2007; 3: 227-34.
26. Palacios S, Tobar AC, Menendez C. Sexuality in the climacteric years. Maturitas 2002; 43 (1 suppl): S69-S77.
27. de Paula FJF, Soares JM, Haidar MA, De Lima GR, Baracat EC. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms. Maturitas 2007; 56: 69-77.
28. Kloosterboer HJ. Tibolone: A steroid with a tissue-specific mode of action. Steroid Biochem Mol Biol 2001; 76: 231-8.
29. Archer DF. Drospirenone and estradiol: A new option for the postmenopausal woman. Climacteric 2007; 10 (1 suppl): 3-10.
30. Basson R, Leiblum S, Brotto L, Derogatis L, Fourcroy J, Fugl-Meyer K, Grazziottin A, Heiman JR, Laan E, Meston C, Schover L, van Lankveld J, Schultz W. Definitions of women's sexual dysfunction reconsidered: Advocating expansion and revision. J Psychosom Obstet Gynaecol 2003; 24: 221-9.